{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-324101","form_type":"8-K","ticker":"CLB","cik":"0001958086","company_name":"Core Laboratories Inc. /DE/","filed_at":"2026-07-29T20:43:31+00:00","discovered_at":"2026-07-29T20:45:00.703034+00:00","generated_at":"2026-07-29T20:45:16.194079+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Core Labs Q2 revenue $124.6M, down 4% YoY; EPS ex-items $0.11, down 42% YoY; declares $0.01 dividend","bullets":["Revenue $124.6M, up 2% sequentially but down 4% YoY; GAAP EPS $0.13, ex-items EPS $0.11.","Operating income ex-items $9.4M, up 42% sequentially but down 36% YoY; operating margin 8%.","Free cash flow $3.1M; repurchased 214,712 shares for $2.7M.","Declared Q3 2026 dividend of $0.01/share, payable Aug 31 to holders of record Aug 10."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-324101","json":"https://secwatch.observer/filing/0001193125-26-324101.json","markdown":"https://secwatch.observer/filing/0001193125-26-324101.md","text":"https://secwatch.observer/filing/0001193125-26-324101.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1958086/000119312526324101/0001193125-26-324101-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1958086/000119312526324101/clb-20260729.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-29T20:45:16.194079+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}